Imagion Biosystems is pleased to present the Company’s annual report for the year ending 31 December 2017.
Read the 2017 Annual Report to Shareholders.
Imagion Appoints New Non-Executive Director, Brett Mitchell
MELBOURNE – Imagion Biosystems (ASX:IBX), a company dedicated to improving healthcare through the early detection of cancer, today announced the appointment of Mr Brett Mitchell